John C Mansfield

7PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersInnate immunityAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 17, 2024
Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine.

Nicola J Wyatt, Hannah Watson, Carl A Anderson

|Sep 14, 2023
Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease.

Robin J Dart, Iva Zlatareva, Pierre Vantourout

|Feb 02, 2023
Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis.

Frank Wagner, John C Mansfield, Annemarie N Lekkerkerker

|Sep 25, 2021
Regulation and Role of αE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease.

Mary E Keir, Franklin Fuh, Ryan Ichikawa

|Jul 02, 2021
Oral Ferric Maltol Does Not Adversely Affect the Intestinal Microbiome of Patients or Mice, But Ferrous Sulphate Does.

Awad Mahalhal, Alessandra Frau, Michael D Burkitt

|Oct 29, 2020
The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation.

Andrew Nelson, Christopher J Stewart, Nicholas A Kennedy

Pageof 2

Frequent Collaborators

4 joint publications

Christopher A Lamb

3 joint publications

Miles Parkes

2 joint publications

Christopher J Stewart

2 joint publications

Nicholas A Kennedy